Will Ashworth

Will Ashworth

InvestorPlace Contributor

Expertise: Public and private companies, Portfolio construction

About Will:
Will Ashworth has written about investments full-time since 2008. He loves investing and is passionate about helping others put their money to work. He particularly enjoys creating model portfolios that stand the test of time.

Publications where he’s appeared include InvestorPlace, The Motley Fool Canada, Investopedia, Kiplinger, and several others in both the U.S. and Canada. He lives in Halifax, Nova Scotia.

You can follow Will on LinkedIn. 

Recent Articles

Sensible Investors Will Ditch Acasti Pharma for Amarin 

By Will Ashworth, InvestorPlace Contributor

Acasti Pharma lost $118 million in market capitalization on January 13. That makes Acasti Pharma stock a liability, not a bargain.

ADBE Stock Is All but Certain to Hit $400 This Year

By Will Ashworth, InvestorPlace Contributor

Shortly after Adobe reported its Q4 2019 results in December, InvestorPlace’s Luke Lango, highlighted the many reasons the company’s stock is a long-term winner. That’s because Adobe’s captured a niche part of the cloud, ensuring that its sales continue to grow for years to come.

Teva Pharmaceutical Just Got a Little Migraine Relief 

By Will Ashworth, InvestorPlace Contributor

With plans to capture 25% of the market, the nod from the FDA should help reduce the sting of having to abandon its planned use of Ajovy for cluster headaches, a move that was dropped last year after a failed phase 3 trial, which gave Eli Lilly the market to itself.

Should JD.com Follow Alibaba’s Hong Kong Listing?

By Will Ashworth, InvestorPlace Contributor

JD.com’s recent bond offering and upcoming spinoff plans suggest the company might not need a secondary listing for JD stock.

Bet On Costco to Beat $312 Over/Under

By Will Ashworth, InvestorPlace Contributor

Despite mean reversion and fears of recession, Oppenheimer upgraded COST to "outperform" on January 21 with a target price for Costco stock of $330.

Don’t Judge CGC Stock on the Beverage Release Miss Alone

By Will Ashworth, InvestorPlace Contributor

Some feel Canopy Growth’s delay launching cannabis-infused drinks is bad for CGC stock. Here’s why that’s not the case. 

Pinterest Stock Should Spark Investors’ Interest With This New Feature

By Will Ashworth, InvestorPlace Contributor

Pinterest just introduced “Try On,” the companies spin on augmented reality. What does this mean for Pinterest stock?

Do Not Put Ocean Power Technologies Stock in Your 401k

By Will Ashworth, InvestorPlace Contributor

The Ocean Renewable Energy Action Coalition just launched. As a result, is Ocean Power Technologies and OPTT stock worth a look?

A Lawsuit Far Away Could Stand in the Way of Micron Stock Hitting $70

By Will Ashworth, InvestorPlace Contributor

In a complicated chain of events, ECD, which created a number of patents related to phase-change memory and the 3D XPoint technology, licensed its intellectual property to Ovonyx, a company created by former Micron CTO Tyler Lowrey and Ovshinsky, to commercialize the technology.

10 of the Top Franchise Stocks to Buy Now 

By Will Ashworth, InvestorPlace Contributor

Entrepreneur magazine’s 2020 Franchise 500 was released in mid-January. Here are 10 of the top franchise stocks to buy now.

Load More